Tag: development

ZUG, Switzerland, July 22, 2025 (GLOBE NEWSWIRE) -- Pharvaris N.V. (“Pharvaris,” Nasdaq: PHVS), a late-stage biopharmaceutical company developing novel, oral bradykinin B2 receptor antagonists to address unmet needs of those living with bradykinin-mediated diseases such as hereditary angioedema (HAE) and acquired angioedema due to C1 inhibitor deficiency (AAE-C1INH), announced today the pricing of an underwritten offering of (i) 8,250,000 of its ordinary shares at a price of $20.00 per share and (ii) to one investor, pre-funded warrants to purchase 500,000 ordinary shares at a price of $19.99 per pre-funded warrant, which represents the per share public offering price for the ordinary shares less the $0.01 per share exercise price for each such pre-funded warrant. All shares and pre-funded warrants in the offering are to be sold by Pharvaris. In addition, Pharvaris has granted the underwriters a 30-day option to purchase up to an additional 1,312,500 ordinary shares at the public offering price, less underwriting discounts and commissions. The gross proceeds to Pharvaris from the offering, before deducting underwriting discounts and commissions and offering expenses, are expected to be approximately $175 million, excluding any exercise of the underwriters’ option to purchase additional shares. The offering is expected to close on or about July 24, 2025, subject to satisfaction of customary closing conditions.

SINGAPORE, July 23, 2025 /PRNewswire/ -- On 17 July 2025, Giti Tire was honoured to be conferred as a 3 heart Company of Good at...

SINGAPORE, July 23, 2025 /PRNewswire/ -- Panduit Corp has been awarded the prestigious Asia Responsible Enterprise Award (AREA) 2025 under the Social Empowerment category...

SINGAPORE, July 23, 2025 /PRNewswire/ -- Panduit Corp has been awarded the prestigious Asia Responsible Enterprise Award (AREA) 2025 under the Social Empowerment category...

Virtu Financial, LTP, Hidden Road Partners, DV Chain, CoinRoutes, and Amber Group included in partner ecosystem to provide deep liquidity and competitive pricing to institutional...

For the first time, fans can help bring the untold story of Jim Thorpe to the screen and honor a legacy long overdue DALLAS, July...

MANILA, Philippines, July 23, 2025 /PRNewswire/ -- The European poultry sector will mark its presence at this year's World Food Expo (WOFEX) on 6–9th...

MANILA, Philippines, July 23, 2025 /PRNewswire/ -- The European poultry sector will mark its presence at this year's World Food Expo (WOFEX) on 6–9th...

82km of drilling and $9M invested in resource development and exploration in Q4, FY25 PERTH, Western Australia, July 23, 2025 /CNW/ - Westgold Resources Limited...

ASX Release $132M Treasury Build in Q4 FY25 PERTH, Western Australia, July 23, 2025 /CNW/ - Westgold Resources Limited (ASX | TSX: WGX - Westgold or the Company) is pleased to report results...

WOBURN, Mass., July 22, 2025 /PRNewswire/ -- Micro Medical Solutions (MMS), a leading innovator in minimally invasive vascular solutions for Critical Limb Ischemia (CLI),...